This represents more recent research with promising preclinical findings
Practical Tips for Consistency While taking a dose late is manageable, the best results come from a consistent routine
The Bottom Line Anti-inflammatory nutrition isnt a trendits a foundation for GLP-1 success
The best choice depends on current weight and BMI, weight-related medical conditions, blood sugar status, cardiovascular risk, liver health, kidney function, medication history, side-effect risk, muscle mass and nutrition status, cost and access, patient preference, and long-term maintenance planning
Overview Wegovy (semaglutide) is a once-weekly prescription injection that helps adults lose weight when diet and exercise alone are not enough
BMI of 27 or higher with weight-related health conditions: Conditions such as type 2 diabetes, hypertension, or cardiovascular disease